ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Eli Lilly launches Mounjaro KwikPen for diabetes, obesity treatment in India
Eli Lilly has launched Mounjaro in KwikPen, a prefilled pen for weekly administration, in India to treat type 2 diabetes and obesity. Priced from Rs 14,000, it offers personalized treatment with six dose strengths. Mounjaro, a dual GIP and GLP-1 receptor a
Announcement as on 13 August 2025

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?
For weight loss drug leaders, the last two weeks have been nothing short of disastrous for shares. Industry pioneer Novo Nordisk A/S (NYSE: NVO) saw its stock drop nearly 22% on July 29 after lowering its full-year guidance. Then, on Aug. 7, Eli Lilly (NYS
Announcement as on 08 August 2025

Eli Lilly stock is tumbling after trial data from oral weight-loss drug

Announcement as on 07 August 2025

UBS slashes target price on Novo Nordisk, citing compounders, Eli Lilly threat

Announcement as on 05 August 2025

Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality and cardiovascular risks. The SURPASS-CVOT trial revealed Mounjaro's superiority over Trulicity, showing improvements
Announcement as on 31 July 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1150.17
  • 12Day Average: 1173.83
  • 20Day Average: 1173.99
  • 50Day Average: 1153.72
  • 100Day Average: 1049.2
  • 150Day Average: 1046.12
  • 200Day Average: 1031.06

LLY Indicators & signals

Indicator MACD (12,26,9)

1163, 1164.63, 9.23
Indicator MACD is in negative zone

Indicator ADX (14)

24.38, 14.36, 23.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Tue Aug 2026 1115.68 1109.16 to 1135.83 -0.51% 1.53 times
03 Mon Aug 2026 1121.36 1109.15 to 1161.94 -2.36% 2.04 times
31 Fri Jul 2026 1148.52 1119.00 to 1162.67 -0.56% 1.09 times
30 Thu Jul 2026 1154.97 1153.14 to 1186.65 -4.57% 2.1 times
29 Wed Jul 2026 1210.32 1204.80 to 1229.19 -0.91% 0.73 times
28 Tue Jul 2026 1221.44 1200.00 to 1232.00 1.97% 0.84 times
27 Mon Jul 2026 1197.88 1183.45 to 1209.45 0.15% 0.5 times
24 Fri Jul 2026 1196.04 1180.01 to 1206.94 0% 0.75 times
24 Fri Jul 2026 1196.04 1180.01 to 1206.94 0.88% 0.75 times
23 Thu Jul 2026 1185.55 1141.78 to 1189.59 1.94% 0.67 times
22 Wed Jul 2026 1163.01 1153.50 to 1179.01 -1.03% 0.53 times
21 Tue Jul 2026 1175.15 1135.00 to 1177.58 2.46% 0.69 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top